California Public Employees Retirement System’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-158,802
Closed -$1.6M 1218
2022
Q4
$1.6M Sell
158,802
-17,402
-10% -$176K ﹤0.01% 1191
2022
Q3
$3.95M Buy
176,204
+37,856
+27% +$848K ﹤0.01% 1150
2022
Q2
$3.43M Hold
138,348
﹤0.01% 1130
2022
Q1
$5.36M Sell
138,348
-22,597
-14% -$876K ﹤0.01% 1118
2021
Q4
$9.42M Sell
160,945
-20,502
-11% -$1.2M 0.01% 1004
2021
Q3
$10.8M Buy
181,447
+2,722
+2% +$161K 0.01% 963
2021
Q2
$15.5M Sell
178,725
-1,952
-1% -$169K 0.01% 791
2021
Q1
$14.9M Buy
180,677
+7,790
+5% +$642K 0.01% 819
2020
Q4
$15.7M Buy
172,887
+10,807
+7% +$983K 0.01% 764
2020
Q3
$6.48M Buy
162,080
+23,560
+17% +$942K 0.01% 1079
2020
Q2
$4.75M Buy
138,520
+3,374
+2% +$116K ﹤0.01% 1232
2020
Q1
$3M Buy
135,146
+11,211
+9% +$249K ﹤0.01% 1345
2019
Q4
$2.43M Sell
123,935
-28,979
-19% -$567K ﹤0.01% 1922
2019
Q3
$2.38M Buy
152,914
+92,628
+154% +$1.44M ﹤0.01% 1783
2019
Q2
$1.22M Buy
60,286
+5,470
+10% +$111K ﹤0.01% 2030
2019
Q1
$963K Sell
54,816
-3,368
-6% -$59.2K ﹤0.01% 2243
2018
Q4
$747K Hold
58,184
﹤0.01% 2377
2018
Q3
$948K Buy
58,184
+41,191
+242% +$671K ﹤0.01% 2355
2018
Q2
$193K Buy
+16,993
New +$193K ﹤0.01% 3015